Elite Pharmaceuticals (ELTP) Cash & Equivalents (2009 - 2026)
Elite Pharmaceuticals' Cash & Equivalents came in at $35.34 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), up 30.5% from $27.08 million a year earlier but down 10.3% from the prior quarter.
Elite Pharmaceuticals (ELTP) Cash & Equivalents (2009 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Elite Pharmaceuticals' Cash & Equivalents was $30.27 million, up 157.2% from FY2025.
- Cash & Equivalents carries a five-year compound annual growth rate of 56.8% (FY2021 to FY2026).
- Going back by fiscal year, Cash & Equivalents was $11.77 million in FY2025 (+56.1%), $7.54 million in FY2024 (-8.6%), $8.24 million in FY2023 (-3.4%) and $8.54 million in FY2022 (+167.3%).
- The five-year range for quarterly Cash & Equivalents is $6.24 million (fiscal Q3 2024) to $39.42 million (fiscal Q1 2027).
- Year-over-year, Cash & Equivalents has increased for nine consecutive quarters, with growth averaging 103.7% over the last eight quarters.
- The fastest year-over-year change in Cash & Equivalents over five years came in fiscal Q1 2023 (growth of 316.3%), and the weakest in fiscal Q3 2024 (a decline of 65.1%).
- Business Quant data shows ELTP's Cash & Equivalents at $39.42 million (Q1 2027), $30.27 million (Q4 2026) and $21.56 million (Q3 2026) in the three fiscal quarters before Q2 2027.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Elite Pharmaceuticals | 401.23 Mn | 274.64 Mn | 15.99 Mn | 35.34 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 35.34 Mn |
| Jun 30, 2026 | 39.42 Mn |
| Mar 31, 2026 | 30.27 Mn |
| Dec 31, 2025 | 21.56 Mn |
| Sep 30, 2025 | 27.08 Mn |
| Jun 30, 2025 | 22.20 Mn |
| Mar 31, 2025 | 11.77 Mn |
| Dec 31, 2024 | 8.74 Mn |
| Sep 30, 2024 | 10.00 Mn |
| Jun 30, 2024 | 8.85 Mn |
| Mar 31, 2024 | 7.54 Mn |
| Dec 31, 2023 | 6.24 Mn |
| Sep 30, 2023 | 9.08 Mn |
| Jun 30, 2023 | 9.49 Mn |
| Mar 31, 2023 | 8.24 Mn |
| Dec 31, 2022 | 17.91 Mn |
| Sep 30, 2022 | 18.56 Mn |
| Jun 30, 2022 | 19.78 Mn |
| Mar 31, 2022 | 8.54 Mn |
| Dec 31, 2021 | 7.29 Mn |
Elite Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ELTP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();